Gynae - Ovarian and Uterine Sarcoma

MULTI-002 Carboplatin and etoposide v1

MULTI-018 Larotrectinib v2

MULTI-019 Entrectinib v2

MULTI-021 Carboplatin and paclitaxel v1

MULTI-029 Olaparib v2

GYN-023 Bevacizumab for 1st line ovarian (induction & maintenance) v5

GYN-035 Carboplatin desensitisation (single agent) v2

GYN-038 Niraparib maintenance after 2nd line (or 2nd and subsequent line if no BRCA mutation) platinum-based chemotherapy v5

GYN-040 Olaparib tablets v3

GYN-041 Rucaparib v2

GYN-042 Trametinib v3

GYN-043 Niraparib maintenance after 1st line platinum based chemotherapy v4

GYN-044 Olaparib and bevacizumab v1
GYN-050 Carboplatin (every 3 weeks) and paclitaxel (weekly) with bevacizumab v1